XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning balance at Dec. 31, 2021 $ 1,849,541 $ 7,175 $ 119,690 $ (359,425) $ 2,070,005 $ 12,096
Beginning balance (in shares) at Dec. 31, 2021   97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 115,607       115,333 274
Other comprehensive income/(loss):            
Translation income/(loss) 706     (185)   891
Defined benefit plan adjustment, net of tax 191     191    
Derivative financial instruments, net of tax 2,550     2,550    
Other comprehensive (loss) income 3,447     2,556   891
Dividends (44,124)       (44,124)  
Issuance of stock awards 377   377      
Issuance of stock awards (in shares)   182        
Shares repurchased (3,410)   (3,410)      
Shares repurchased (in shares)   (60)        
Share-based compensation 10,689   10,689      
Purchase of noncontrolling interest (13,196)   (7,080)     (6,116)
Ending balance at Apr. 03, 2022 1,918,931 $ 7,175 120,266 (356,869) 2,141,214 7,145
Ending balance (in shares) at Apr. 03, 2022   97,492        
Beginning balance at Dec. 31, 2021 1,849,541 $ 7,175 119,690 (359,425) 2,070,005 12,096
Beginning balance (in shares) at Dec. 31, 2021   97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 247,374          
Other comprehensive income/(loss):            
Translation income/(loss) (69,608)          
Defined benefit plan adjustment, net of tax (1,737)          
Derivative financial instruments, net of tax 460          
Other comprehensive (loss) income       (71,252)    
Ending balance at Jul. 03, 2022 1,936,391 $ 7,175 128,332 (430,677) 2,224,845 6,716
Ending balance (in shares) at Jul. 03, 2022   97,495        
Beginning balance at Apr. 03, 2022 1,918,931 $ 7,175 120,266 (356,869) 2,141,214 7,145
Beginning balance (in shares) at Apr. 03, 2022   97,492        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 131,767       131,672 95
Other comprehensive income/(loss):            
Translation income/(loss) (70,314)     (69,790)   (524)
Defined benefit plan adjustment, net of tax (1,928)     (1,928)    
Derivative financial instruments, net of tax (2,090)     (2,090)    
Other comprehensive (loss) income (74,332)     (73,808)   (524)
Dividends (48,041)       (48,041)  
Issuance of stock awards 263   263      
Issuance of stock awards (in shares)   13        
Shares repurchased (574)   (574)      
Shares repurchased (in shares)   (10)        
Share-based compensation 8,377   8,377      
Ending balance at Jul. 03, 2022 1,936,391 $ 7,175 128,332 (430,677) 2,224,845 6,716
Ending balance (in shares) at Jul. 03, 2022   97,495        
Beginning balance at Dec. 31, 2022 $ 2,072,797 [1] $ 7,175 140,539 (430,083) 2,348,183 6,983
Beginning balance (in shares) at Dec. 31, 2022 97,645 97,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 148,264       148,319 (55)
Other comprehensive income/(loss):            
Translation income/(loss) 31,808     31,569   239
Defined benefit plan adjustment, net of tax 916     916    
Derivative financial instruments, net of tax 2,514     2,514    
Other comprehensive (loss) income 35,238     34,999   239
Dividends (48,203)       (48,203)  
Issuance of stock awards 472   472      
Issuance of stock awards (in shares)   485        
Shares repurchased (10,576)   (10,576)      
Shares repurchased (in shares)   (175)        
Share-based compensation 7,573   7,573      
Ending balance at Apr. 02, 2023 2,205,565 $ 7,175 138,008 (395,084) 2,448,299 7,167
Ending balance (in shares) at Apr. 02, 2023   97,955        
Beginning balance at Dec. 31, 2022 $ 2,072,797 [1] $ 7,175 140,539 (430,083) 2,348,183 6,983
Beginning balance (in shares) at Dec. 31, 2022 97,645 97,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 263,013          
Other comprehensive income/(loss):            
Translation income/(loss) 53,498          
Defined benefit plan adjustment, net of tax (847)          
Derivative financial instruments, net of tax 3,942          
Other comprehensive (loss) income       56,652    
Ending balance at Jul. 02, 2023 $ 2,299,322 $ 7,175 145,841 (373,431) 2,512,768 6,969
Ending balance (in shares) at Jul. 02, 2023 97,956 97,956        
Beginning balance at Apr. 02, 2023 $ 2,205,565 $ 7,175 138,008 (395,084) 2,448,299 7,167
Beginning balance (in shares) at Apr. 02, 2023   97,955        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 114,749       114,649 100
Other comprehensive income/(loss):            
Translation income/(loss) 21,690     21,988   (298)
Defined benefit plan adjustment, net of tax (1,763)     (1,763)    
Derivative financial instruments, net of tax 1,428     1,428    
Other comprehensive (loss) income 21,355     21,653   (298)
Dividends (50,180)       (50,180)  
Issuance of stock awards 222   222      
Issuance of stock awards (in shares)   1        
Shares repurchased (26)   (26)      
Shares repurchased (in shares)   0        
Share-based compensation 7,637   7,637      
Ending balance at Jul. 02, 2023 $ 2,299,322 $ 7,175 $ 145,841 $ (373,431) $ 2,512,768 $ 6,969
Ending balance (in shares) at Jul. 02, 2023 97,956 97,956        
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (the “United States” or “U.S.”).